Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
QCLS
Q/C TECHNOLOGIES, INC.
NASDAQ · In Vitro & In Vivo Diagnostic Substances
Last close
$0.85
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
In Vitro & In Vivo Diagnostic Substances
Market cap
$6.97M
RECENT INSIDER TRADES
2026-10-02
· Silverman Joshua
(Executive Chairman)
· OTHER
2026-05-14
· Voss Chelsea Sierra
(Director)
· BUY
2026-04-15
· Silverman Joshua
(Executive Chairman)
· OTHER
2025-11-18
· PharmaCyte Biotech, Inc.
(10% Owner)
· BUY
INSTITUTIONAL OWNERSHIP
Institutional holders
23
Shares held
791,568
Value
$2.88M
Percent of shares outstanding
9.67%
As of quarter end
2026-06-30
RECENT NEWS
Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab
Q/C Technologies Announces Research Collaboration with Sandia National Laboratories, a $5 Billion U.S. Department of Energy Lab
QCLS halted · Volatility pause (LULD)
QCLS halted · Volatility pause (LULD)
QCLS halted · Volatility pause (LULD)
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Q/C TECHNOLOGIES, INC. (QCLS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit